Patents

US 11266772 B2: Use of heparin and carbohydrates to treat cancer

Granted
2022-03-08
Filed
2014-12-09 application 14565387
Type
Utility · 6 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The method is described as the removal of mediators that contribute to the pathogenesis of cancer from blood by contacting the blood with a solid, essentially non-micro-porous substrate which has been surface treated with heparin, heparan sulfate and, optionally, other molecules or chemical groups (the adsorbent media or media) having a binding affinity to the mediator, and wherein the size of the interstitial channels within said substrate are balanced with the amount of interstitial substrate surface area such that high flow rates of blood past said substrate creates a flow transport that is characterized by convection transport more than Brownian diffusion transport.

Source: PVGPATDIS, file of 2026-04-10 (ipg220308.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
EXTHERA MEDICAL CORPORATION 22 patentsUS company or organizationMartinez, CAExThera Medical Corp Form D issuer FUZZY medium confidence: same name (legal endings aside) and statePVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Keith R. McCreaConcord, CA22PVGPATDIS, file of 2026-04-10
Robert S. WardOrinda, CA28PVGPATDIS, file of 2026-04-10
Olle LarmBromma, SE14PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61MDevices for introducing media into, or onto, the body ; devices for transducing body media or for taking media from the body ; devices for producing or ending sleep or stuporA61M1/34PVGPATDIS, file of 2026-04-10
A61KPreparations for medical, dental or toiletry purposesA61K31/727PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2021-11-24Name change
Change of address
EXTHERA MEDICAL CORPORATION signed 2021-11-18EXTHERA MEDICAL CORPORATION MARTINEZ, CA58950/25ECORSEXC, file of 2026-09-25
2015-12-29Assignment
Assignment of assignor's interest
LARM, OLLE signed 2015-12-21EXTHERA MEDICAL CORPORATION BERKELEY, CA37379/746ECORSEXC, file of 2026-09-25
2015-01-16Assignment
Assignment of assignor's interest
MCCREA, KEITH signed 2014-12-16
WARD, ROBERT signed 2014-12-16
EXTHERA MEDICAL CORPORATION BERKELEY, CA34740/702ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.